Maze Therapeutics, Inc. · NASDAQ:MAZE

Coloma Jason V sold 6,643 Maze Therapeutics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Coloma Jason V (Director, Chief Executive Officer) sold 6,643 Maze Therapeutics, Inc. shares at an average US$26.20 for US$174K under a trading plan, leaving 27,970 shares. Filed Jun 3, 2026 (Form 4).

Sold
6,643 shares
Price
US$26.20 average (US$26.20 to US$26.24)
Value
US$174K
Holding after
27,970 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockSale6,090US$26.20344,897Indirect
Jun 1, 2026Common StockSale553US$26.2427,970Indirect

Source

View original at SEC

Related